Methotrexate accumulation and folate depletion in cells as a possible mechanism of chronic toxicity to the drug
- PMID: 6170307
- DOI: 10.1111/j.1365-2141.1981.tb07237.x
Methotrexate accumulation and folate depletion in cells as a possible mechanism of chronic toxicity to the drug
Abstract
Methotrexate has been associated with chronic toxicities such as cirrhosis and neurological impairments ranging from mild learning disorders to a fatal leucoencephalopathy. The mechanism(s) for this toxicity is not completely understood. Certain tissues can convert methotrexate to polyglutamates. This results in a more persistent intracellular form of the drug. In this study the intracellular levels of folate and methotrexate were measured in the erythrocytes and liver of patients treated chronically with methotrexate. These tissues showed an accumulation of methotrexate as polyglutamates and a concomitant loss of folate. Folate concentrations were below normal in nine of 12 red cell and three of five liver samples. It is proposed that persistent methotrexate concentrations and/or the associated folate deficiency may be related to the toxicity of methotrexate, especially in time of cellular stress.
Similar articles
-
Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates.Arthritis Rheum. 1986 Jul;29(7):832-5. doi: 10.1002/art.1780290703. Arthritis Rheum. 1986. PMID: 2427090
-
Methotrexate polyglutamate synthesis in lymphoblasts from children with acute lymphoblastic leukemia.Dev Pharmacol Ther. 1987;10(6):443-8. doi: 10.1159/000457776. Dev Pharmacol Ther. 1987. PMID: 2445535
-
Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis.Biochem Pharmacol. 2002 Jan 15;63(2):105-15. doi: 10.1016/s0006-2952(01)00824-3. Biochem Pharmacol. 2002. PMID: 11841783
-
Interaction of methotrexate polyglutamates and dihydrofolate during leucovorin rescue in a human breast cancer cell line (MCF-7).Cancer Res. 1990 Jun 15;50(12):3574-8. Cancer Res. 1990. PMID: 1692762
-
Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases.Pharmacogenomics. 2011 Oct;12(10):1449-63. doi: 10.2217/pgs.11.86. Pharmacogenomics. 2011. PMID: 22008049 Review.
Cited by
-
Acute folic acid deficiency after bone marrow transplantation.Klin Wochenschr. 1986 May 2;64(9):423-32. doi: 10.1007/BF01727528. Klin Wochenschr. 1986. PMID: 3520134
-
Effect of an Extract from the Egyptian Sea Cucumber, Bohadschia marmorata, on Methotrexate-Induced Hepatorenal Toxicity in Male Mice.Asian Pac J Cancer Prev. 2022 Feb 1;23(2):703-713. doi: 10.31557/APJCP.2022.23.2.703. Asian Pac J Cancer Prev. 2022. PMID: 35225484 Free PMC article.
-
Pharmacokinetics of methotrexate in erythrocytes in psoriasis.Eur J Clin Pharmacol. 1984;27(5):607-10. doi: 10.1007/BF00556900. Eur J Clin Pharmacol. 1984. PMID: 6519167
-
Enhanced therapeutic effect of methotrexate in experimental rat leukemia after inactivation of cobalamin (vitamin B12) by nitrous oxide.Cancer Chemother Pharmacol. 1986;17(2):114-20. doi: 10.1007/BF00306738. Cancer Chemother Pharmacol. 1986. PMID: 3719892
-
Hepatotoxicity of methotrexate in rheumatic diseases.Med Toxicol Adverse Drug Exp. 1988 May-Jun;3(3):197-208. doi: 10.1007/BF03259882. Med Toxicol Adverse Drug Exp. 1988. PMID: 3041245 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical